 |
Trials |
A Multicenter, Open-Label Phase 1b/2 Trial of LenvatinibCancer type: Renal cancer Phase: I/II Principal Investigator: Guren Tormod Country: NO Keywords: Norway, Oslo, renal cell cancer Status: Inclusion completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02501096?term=e7080-a001&rank=6 |